Skip to content

Clinical research

Clinical trial sites in Asia-Pacific

Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.

  • Trial site
  • Group of pins (click to zoom)

Showing the 40,000 busiest of 156,725 located sites. The map holds only the first 40,000, so narrow the filters to see the rest.

Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.

Looking for contract research suppliers and CROs? Visit Contract Research Map

Filters: Region: Asia-Pacific Clear all

Trial sites by region

Select a bar to filter by region.

Scale
Trial sites by region
CategoryTrial sites
Europe473,828
North America335,343
Asia-Pacific156,725
Latin America45,749
Africa19,472
Middle East14,322
Other3,140

Top countries

Country of the site's address. Select a bar to filter.

Scale

Bar colour shows the country's region, as in the chart by region.

Trial sites by country
CategoryTrial sites
China45,895
Japan38,740
Australia16,429
South Korea13,453
India12,713
Taiwan6,732
Pakistan3,797
Thailand3,339

Trial sites

156,725 sites. Sites with a public page link to it on Pharma Observatory.

  • Monash Medical Centre Melbourne, Australia Ongoing trial 17 trials
  • NHO Kyushu Cancer Center Fukuoka, Japan Ongoing trial 17 trials
  • Nanyang Central Hospital Nanyang, China Ongoing trial 17 trials
  • National Cancer Center Goyang-si Gyeonggi-do, South Korea Ongoing trial 17 trials
  • National Cancer Center Goyang-si, Kyǒnggi-do, South Korea Ongoing trial 17 trials
  • Nepean Hospital Kingswood, Australia Ongoing trial 17 trials
  • Novartis Investigative Site Hirakata, Osaka, Japan Ongoing trial 17 trials
  • Novartis Investigative Site Seongnam-si, Gyeonggi-do, South Korea Ongoing trial 17 trials
  • Novartis Investigative Site Saitama, Saitama, Japan Ongoing trial 17 trials
  • Novartis Investigative Site Ludhiana, Punjab, India Ongoing trial 17 trials
  • Novartis Investigative Site Madurai, Tamil Nadu, India Ongoing trial 17 trials
  • Novartis Investigative Site Himeji, Hyōgo, Japan Ongoing trial 17 trials
  • Novartis Investigative Site Toyama, Toyama, Japan Ongoing trial 17 trials
  • Novartis Investigative Site Kodaira, Tokyo, Japan Ongoing trial 17 trials
  • Novartis Investigative Site Nanning, Guangxi, China Ongoing trial 17 trials
  • Novartis Investigative Site Ipoh, Perak, Malaysia Ongoing trial 17 trials
  • Novartis Investigative Site Bucheon-si, Gyeonggi-do, South Korea Ongoing trial 17 trials
  • Novartis Investigative Site Kota Kinabalu, Sabah, Malaysia Ongoing trial 17 trials
  • Novartis Investigative Site Izumo, Shimane, Japan Ongoing trial 17 trials
  • Novo Nordisk Investigational Site Jaipur, Rajasthan, India 17 trials

Explore the data behind the map on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.